BioNTech inaugurates 1st manufacturing plant for mRNA vaccines in Africa
[ad_1]
Facility could initially manufacture up to 50M doses annually
[ad_2]
Source link
[ad_1]
Facility could initially manufacture up to 50M doses annually
[ad_2]
Source link